tirzepatide mc4r weight loss
5 Reasons Tirzepatide Outshines Semaglutide on MC4R
In 2024 tirzepatide has been shown to outshine semaglutide in patients with MC4R deficiency, delivering markedly greater weight loss and added cardiometabolic benefits. The advantage stems from its dual GIP/GLP-1 activity, which bypasses the faulty melanocortin pathway that limits semaglutide’s effect. Medical Disclaimer: This article is for informational